RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Double Point Ventures
D

Double Point Ventures portfolio

Double Point Ventures has 2 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months. It led 2 of the 2 rounds it joined. Its most recent investment on record is Synchron's $200M Series B+ round in November 2025, which it led, alongside T.Rx Capital, Qatar Investment Authority, Protocol Labs and 6 others. By category, its portfolio leans toward Health and bio (2) and Manufacturing and industrial (2). It has co-invested with Khosla Ventures, K5 Global and Protocol Labs.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 1.
Rounds led: 2 of 2.
Capital in their rounds: $300M.
Latest deal: Synchron · Nov 6, 2025.

What Double Point Ventures invests in

How Double Point Ventures invests

StageDealsCapital in rounds
Series B+ 2 100%$300M

Share is of the 2 rounds on Recent Funding that name Double Point Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Double Point Ventures portfolio companies

CompanyRound with Double Point VenturesTotal raisedLatest raise
SSynchron
Health and bio
 Series B+ · $200M · lead$600MJun 29, 2026
Series B+
UUmoja Biopharma
Health and bio
 Series B+ · $100M · lead$363MJan 14, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

Portfolio companies are the companies on Recent Funding with a round that lists Double Point Ventures, which is a subset of its real portfolio. API: /api/v1/investors/double-point-ventures (get a free API key). More: the most active VC firms and new venture capital funds.